27738051|t|Identification of Chlamydia trachomatis Antigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection
27738051|a|Natural infection induces partial immunity to Chlamydia trachomatis Identification of chlamydial antigens that induce interferon γ (IFN-) secretion by T cells from immune women could advance vaccine development. IFN-γ production by CD4(+) and CD8(+) peripheral blood T cells from 58 high-risk women was measured after coculture with antigen-presenting cells preincubated with recombinant Escherichia coli expressing a panel of 275 chlamydial antigens. Quantile median regression analysis was used to compare frequencies of IFN-γ responses in women with only cervical infection to those in women with endometrial infection and frequencies in women who remained uninfected for over 1 year to those in women who developed incident infection. Statistical methods were then used to identify proteins associated with protection. A higher median frequency of CD8(+) T-cell responses was detected in women with lower genital tract chlamydial infection, compared with those with upper genital tract chlamydial infection (13.8% vs 9.5%; P =04), but the CD4(+) T-cell response frequencies were not different. Women who remained uninfected displayed a greater frequency of positive CD4(+) T-cell responses (29% vs 18%; P < .0001), compared with women who had incident infection, while the frequencies of CD8(+) T-cell responses did not differ. A subset of proteins involved in central metabolism, type III secretion, and protein synthesis were associated with protection. Investigations in naturally exposed women reveal protective responses and identify chlamydial vaccine candidate antigens.
27738051	0	14	Identification	T080	C0205396
27738051	18	48	Chlamydia trachomatis Antigens	T129	C0368903
27738051	49	59	Recognized	T080	C0205396
27738051	63	70	T Cells	T025	C0039194
27738051	83	90	Exposed	T080	C0332157
27738051	91	96	Women	T098	C0043210
27738051	101	106	Limit	T169	C0439801
27738051	110	116	Resist	T169	C4281815
27738051	117	140	Genital Tract Infection	T047	C1263758
27738051	141	148	Natural	T169	C0205296
27738051	149	158	infection	T046	C3714514
27738051	167	174	partial	T081	C0728938
27738051	175	183	immunity	T039	C0020964
27738051	187	208	Chlamydia trachomatis	T007	C0008151
27738051	209	223	Identification	T080	C0205396
27738051	227	246	chlamydial antigens	T129	C0368903
27738051	259	271	interferon γ	T116,T121,T129	C3539881
27738051	273	277	IFN-	T116,T121,T129	C3539881
27738051	279	288	secretion	T043	C1327616
27738051	292	299	T cells	T025	C0039194
27738051	305	311	immune	T169	C0439662
27738051	312	317	women	T098	C0043210
27738051	332	351	vaccine development	T062	C0597634
27738051	353	358	IFN-γ	T116,T121,T129	C3539881
27738051	373	379	CD4(+)	T025	C0039215
27738051	384	390	CD8(+)	T025	C0242629
27738051	391	407	peripheral blood	T031	C0229664
27738051	408	415	T cells	T025	C0039194
27738051	434	439	women	T098	C0043210
27738051	459	468	coculture	T059	C0282547
27738051	474	498	antigen-presenting cells	T025	C0003315
27738051	517	528	recombinant	T001	C1514798
27738051	529	545	Escherichia coli	T007	C0014834
27738051	572	591	chlamydial antigens	T129	C0368903
27738051	593	628	Quantile median regression analysis	T170	C0034980
27738051	641	648	compare	T052	C1707455
27738051	649	660	frequencies	T079	C0439603
27738051	664	669	IFN-γ	T116,T121,T129	C3539881
27738051	670	679	responses	T042	C0301872
27738051	683	688	women	T098	C0043210
27738051	699	717	cervical infection	T047	C1392348
27738051	730	735	women	T098	C0043210
27738051	741	752	endometrial	T023	C0014180
27738051	753	762	infection	T046	C3714514
27738051	767	778	frequencies	T079	C0439603
27738051	782	787	women	T098	C0043210
27738051	801	811	uninfected	T169	C0521118
27738051	823	827	year	T079	C0439234
27738051	840	845	women	T098	C0043210
27738051	860	868	incident	T067	C1551358
27738051	869	878	infection	T046	C3714514
27738051	880	899	Statistical methods	T062	C1710191
27738051	918	926	identify	T080	C0205396
27738051	927	935	proteins	T116,T123	C0033684
27738051	936	951	associated with	T080	C0332281
27738051	952	962	protection	T039	C0020964
27738051	980	989	frequency	T079	C0439603
27738051	993	1006	CD8(+) T-cell	T025	C0242629
27738051	1007	1016	responses	T043	C1318468
27738051	1033	1038	women	T098	C0043210
27738051	1044	1049	lower	T082	C0441994
27738051	1050	1063	genital tract	T022	C0700038
27738051	1064	1084	chlamydial infection	T047	C0008149
27738051	1086	1094	compared	T052	C1707455
27738051	1111	1116	upper	T082	C1282910
27738051	1117	1130	genital tract	T022	C0700038
27738051	1131	1151	chlamydial infection	T047	C0008149
27738051	1184	1197	CD4(+) T-cell	T025	C0039215
27738051	1207	1218	frequencies	T079	C0439603
27738051	1239	1244	Women	T098	C0043210
27738051	1258	1268	uninfected	T169	C0521118
27738051	1289	1298	frequency	T079	C0439603
27738051	1311	1324	CD4(+) T-cell	T025	C0039215
27738051	1325	1334	responses	T043	C1318468
27738051	1360	1368	compared	T052	C1707455
27738051	1374	1379	women	T098	C0043210
27738051	1388	1396	incident	T067	C1551358
27738051	1397	1406	infection	T046	C3714514
27738051	1418	1429	frequencies	T079	C0439603
27738051	1433	1446	CD8(+) T-cell	T025	C0242629
27738051	1447	1456	responses	T043	C1318468
27738051	1475	1481	subset	T185	C1515021
27738051	1485	1493	proteins	T116,T123	C0033684
27738051	1506	1524	central metabolism	T040	C0025519
27738051	1526	1544	type III secretion	T043	C3156721
27738051	1550	1567	protein synthesis	T044	C0597295
27738051	1589	1599	protection	T039	C0020964
27738051	1601	1615	Investigations	T169	C1292732
27738051	1629	1636	exposed	T080	C0332157
27738051	1637	1642	women	T098	C0043210
27738051	1661	1670	responses	T043	C1318468
27738051	1675	1683	identify	T080	C0205396
27738051	1684	1721	chlamydial vaccine candidate antigens	T109,T121,T129	C1519887